- Home
- Pharmaceuticals
- 040-000-284 Hydroxychloroquine Sulfate, CAS 747-36-4
040-000-284 Hydroxychloroquine Sulfate, CAS 747-36-4
Synonyms | 2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol sulfate, Hydroxychloroquine sulphate, Ercoquin |
Key words | Autophagy inhibitor; also TLR9 inhibitor; COVID-19 |
Related products | Remdesivir (development code GS-5734); Losartan Potassium, cell metabolism, autophagy |
Stanford Chemicals Company is a leading Hydroxychloroquine Sulfate wholesale supplier in the USA. The bulk Hydroxychloroquine sulfate powder is for sale.
- Description
Description
Hydroxychloroquine Sulfate Specifications
Product Name | Hydroxychloroquine Sulfate |
CAS Registry Number | 747-36-4 |
Molecular Formula | C18H28ClN3O5S |
Molecular Weight | 433.95 g/mol |
Purity | ≥99% (HPLC) |
Package | 1kg-25kg |
Shelf life | 2 years |
Functions | 1. Autophagy inhibitor. Inhibits growth and induces apoptosis of renal cancer cells in vitro.
2. Also inhibits TLR9. 3. Additionally inhibits PRC2 by inhibiting the allosteric binding of PRC2 to EED (embryonic ectoderm development) within the H3K27me3-binding pocket, and reduces H3K27me3 levels in multiple myeloma cells in vitro. |
Used for | acute malaria, discoid lupus erythematosus (DLE), systemic lupus erythematosus, rheumatoid arthritis |
Hydroxychloroquine Sulfate Description
Hydroxychloroquine is usually taken with food or milk to prevent stomach upset. It was approved for medical use in the United States in 1955. It regulates the activity of the immune system and modifies the underlying disease process, rather than simply treating the symptoms. Hydroxychloroquine sulfate works by reducing inflammation in people with autoimmune diseases.
Hydroxychloroquine Sulfate Used for:
- Hydroxychloroquine is used to treat Rheumatoid arthritis, Discoid and systemic lupus erythematosus (SLE)
- Hydroxychloroquine can be used as an antimalarial drug to treat malaria
- Enzyme inhibitors
Reference:
- Lee et al (2015) Hydroxychloroquine Destabilizes Phospho-S6 in Human Renal Carcinoma Cells. PLoS ONE 10 e0131464 PMID: 26134285
- Lamphier et al (2014) Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo. Mol.Pharmacol. 85 429 PMID: 24342772
- Catalano et al (2019) A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. Eur.J.Med.Chem. 183 PMID: 31550663